Both products launched in Canadian pharmacies in May 2026 at roughly $100$150 per month, making Canada the first G7 country to approve a generic version of semaglutide
P6C can trap pyridoxal-5-phosphate (PLP), the active form of vitamin B 6 (pyridoxine), leading to a deficiency in PLP, which is corrected with supplemental pyridoxine
FDA Approval and Cost Considerations Tirzepatide is still waiting for its FDA approval for weight management, while Ozempic has been flaunting both its diabetes and weight management approvals for a while now
With that said, its still important to understand the fact that there are side effects associated with iPamorelin
Our experience shows that preparation is 90% of the battle
If youre supplementing glutathione for liver support, time it on days 46 post-injection to avoid overlapping with peak GI side effects